
Bruker Corporation BRKR
$ 47.51
-1.92%
Quarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Interest Expense 2011-2025 | BRKR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38.2 M | -36.8 M | -18.8 M | 14.3 M | 14.4 M | 16 M | 12.6 M | 15.4 M | 13.2 M | 13 M | 13.3 M | 13.4 M | 14.3 M | 7.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16 M | -38.2 M | 3.81 M |
Quarterly Interest Expense Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 M | -6.7 M | - | -12.8 M | 15.7 M | 6.8 M | - | 3.9 M | 3.9 M | 4.2 M | - | 3.7 M | -4 M | 4.1 M | - | - | - | - | - | - | - | - | - | - | -100 K | -500 K | - | 100 K | -100 K | 600 K | - | 800 K | 2.4 M | - | - | 500 K | -400 K | -200 K | - | 500 K | - | - | - | 3.2 M | 3.1 M | 3 M | - | 3.2 M | 3.1 M | 3.1 M | - | 3.4 M | 3.5 M | 3.3 M | - | 1.7 M | 1.6 M | 1.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.7 M | -20 M | 1.06 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
58.7 M | - | - | $ 17.2 B | ||
|
Alphatec Holdings
ATEC
|
24.9 M | $ 20.86 | -0.57 % | $ 2.98 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 9.3 | - | $ 668 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.44 | -1.71 % | $ 119 M | ||
|
Boston Scientific Corporation
BSX
|
305 M | $ 96.01 | 0.26 % | $ 141 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 304.51 | 0.26 % | $ 8.59 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Electromed
ELMD
|
78 K | $ 28.83 | 1.3 % | $ 244 M | ||
|
Abbott Laboratories
ABT
|
376 M | $ 125.78 | 0.97 % | $ 219 B | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.21 | -0.62 % | $ 120 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 97.77 | 0.03 % | $ 1.24 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
LivaNova PLC
LIVN
|
1.01 M | $ 62.28 | -0.29 % | $ 3.38 B | ||
|
LENSAR
LNSR
|
660 K | $ 11.63 | -1.86 % | $ 134 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 158.14 | 0.19 % | $ 11.8 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
13 M | $ 0.8 | -0.2 % | $ 82.2 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 13.57 | -0.59 % | $ 367 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.6 | 26.88 % | $ 122 M | ||
|
AxoGen
AXGN
|
-199 K | $ 32.73 | -2.15 % | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Orthofix Medical
OFIX
|
-9.62 M | $ 15.33 | -0.97 % | $ 585 M | ||
|
CONMED Corporation
CNMD
|
37.3 M | $ 41.14 | -0.82 % | $ 1.27 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-1.07 M | $ 17.96 | 1.87 % | $ 414 M | ||
|
Globus Medical
GMED
|
2.2 M | $ 87.91 | -0.51 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 12.68 | 0.56 % | $ 976 M |